A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...

Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older against fleas and ticks.

The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...

Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: ...

Merck Animal Health announced on Sept. 22 that it has acquired Vence from its founders and shareholders. Vence is an innovator in virtual fencing for rotational grazing and livestock management.

Merck & Co.'s (MRK) animal health segment operates in more than 140 countries worldwide. Global revenues for 1Q16 were $829 million, which was no change compared to 1Q15.

Contacts. For Merck Animal Health Media: Pam Eisele, 267-305-3558 Noreen Verbrugge, 973-937-5450 or Investors: Teri Loxam, 908-740-1986 Justin Holko, 908-740-1879 ...

(Reuters) -Merck Animal Health, a unit of Merck, said on Thursday it would invest $895 million to expand its manufacturing facility in De Soto, Kansas.